Drug Profile
KAN 0439782
Alternative Names: KAN-0439782Latest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator Kancera
- Class Antineoplastics; Small molecules
- Mechanism of Action HDAC6 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Multiple myeloma
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for research development in Breast-cancer in Sweden
- 28 Jul 2019 No recent reports of development identified for research development in Multiple-myeloma in Sweden